CDC Grand Rounds: global tobacco control
Asma S, Song Y, Cohen J, Eriksen M, Pechacek T, Cohen N, Iskander J, MMWR Morb Mortal Wkly Rep, 4/4/2014CDC Grand Rounds: a public health approach to prevention of intimate partner violence
Spivak HR, Jenkins L, VanAudenhove K, Lee D, Kelly M, Iskander J, MMWR Morb Mortal Wkly Rep, 1/17/2014CDC grand rounds: Reducing the burden of HPV-associated cancer and disease
Dunne EF, Markowitz LE, Saraiya M, Stokley S, Middleman A, Unger ER, Williams A, Iskander J, MMWR Morb Mortal Wkly Rep, 1/1/2014CDC Grand Rounds: Evidence-based injury prevention
Spivak HR, Jenkins L, VanAudenhove K, Lee D, Kelly M, Iskander J, MMWR Morb Mortal Wkly Rep, 1/1/2014Public Health Grand Rounds at the Centers for Disease Control and Prevention: Evaluation Feedback From a Broad Community of Learners
Iskander J, Ari M, Chen B, Hall S, Ghiya N, Popovic T, J Public Health ManagPract., 10/4/2013CDCGrand Rounds: public health approaches to reducing US infant mortality
Iskander J, Strikas RA, Gensheimer KF, Cox NJ, Redd SC, MMWR Morb Mortal Wkly Rep, 8/9/2013Pandemic influenza planning, United States, 1978-2008
Iskander J, Strikas RA, Gensheimer KF, Cox NJ, Redd SC, Emerg Infect Dis, 6/1/2013CDCGrand Rounds: preventing unsafe injection practices in the US health-care system
Iskander J, Strikas RA, Gensheimer KF, Cox NJ, Redd SC, MMWR Morb Mortal Wkly Rep, 5/31/2013CDCGrand Rounds: the growing threat of multidrug-resistant gonorrhea
Iskander J, Strikas RA, Gensheimer KF, Cox NJ, Redd SC, MMWR Morb Mortal Wkly Rep, 2/15/2013Internet-based reporting to the vaccine adverse event reporting system: a more timely and complete way for providers to support vaccine safety
Haber P, Iskander J, Walton K, Campbell SR, Kohl KS, Pediatrics, 5/1/2011Tracking vaccine-safety inquiries to detect signals and monitor public concerns
Miller E, Batten B, Hampton L, Campbell SR, Gao J, Iskander J, Pediatrics, 5/1/2011Thrombocytopenia after vaccination: Case reports to the US Vaccine Adverse Event Reporting System, 1990-2008
Woo EJ, Wise RP, Menschik D, Shadomy SV, Iskander J, Beeler J, Varricchio FA, Ball R, Vaccine, 11/29/2010Adverse event reports following Japanese encephalitis vaccination in the United States, 1999-2009
Lindsey NP, Staples JE, Jones JF, Sevjar JJ, Griggs A, Iskander J, Miller ER, Fischer M, Vaccine, 10/20/2010Centers for Disease Control and Prevention (CDC) Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices...
Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, Iskander JK, Wortley PM, Shay DK, Bresee JS, Cox NJ, MMWR Recomm Rep., 8/6/2010Lack of Association BetweenAcellular Pertussis Vaccine and Seizures in Early Childhood
Huang WT, Gargiullo PM, Broder KR, Weintraub ES, Iskander JK, Klein NP, Baggs JM; for the Vaccine Safety Datalink Team, Pediatrics, 7/19/2010Safety assessment of recalled Haemophilusinfluenzae type b (Hib) conjugate vaccines--United States, 2007-2008
Huang WT, Chang S, Miller ER, Jane Woo E, Hoffmaster AR, Gee JE, Clark TA, Iskander JK, Ball R, Broder KR, Pharmacoepidemiol Drug Saf, 3/1/2010Kawasaki Disease After Vaccination: Reports to the Vaccine Adverse Event Reporting System 1990-2007
Hua W, Izurieta HS, Slade B, Belay ED, Haber P, Tiernan R, Woo EJ, Iskander J, Braun MM, Ball R, Pediatr Infect Dis J., 11/1/2009Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study
Jackson LA, Yu O, Belongia EA, Hambidge SJ, Nelson J, Baxter R, Naleway A, Gay C, Nordin J, Baggs J, Iskander J, BMC Infect Dis, 10/1/2009Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine
Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, Izurieta HS, Ball R, Miller N, Braun MM, Markowitz LE, Iskander J, JAMA, 8/19/2009Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study
Jackson LA, Yu O, Nelson J, Belongia EA, Hambidge SJ, Baxter R, Naleway A, Nordin J, Baggs J, Iskander J, Vaccine, 8/6/2009Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009
Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NJ; Centers for Disease Control and Prevention, MMWR Recomm Rep, 7/31/2009Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6-23 months of age
Rosenberg M, Sparks R, McMahon A, Iskander J, Campbell JD, Edwards KM, Vaccine, 7/9/2009Death and serious illness following influenza vaccination: a multidisciplinary investigation
Rue-Cover A, Iskander J, Lyn S, Burwen DR, Gargiullo P, Shadomy S, Blostein J, Bridges CB, Haber P, Satzger RD, Ball R, Seward JF, Pharmacoepidemiol Drug Saf., 6/1/2009Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008
Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NS; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization ..., MMWR Recomm Rep., 8/8/2008Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome
Nachamkin I, Shadomy SV, Moran AP, Cox N, Fitzgerald C, Ung H, Corcoran AT, Iskander JK, Schonberger LB, Chen RT, J Infect Dis, 7/15/2008- Join now to see all